J.W. Cole Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
20,981
+663
| +3% | +$46.3K | 0.03% | 536 |
|
|
2025
Q1 | $1.49M | Buy |
20,318
+15,776
| +347% | +$1.16M | 0.05% | 401 |
|
|
2024
Q4 | $298K | Sell |
4,542
-964
| -18% | -$63.2K | 0.01% | 784 |
|
|
2024
Q3 | $429K | Sell |
5,506
-48
| -0.9% | -$3.74K | 0.02% | 652 |
|
|
2024
Q2 | $433K | Sell |
5,554
-618
| -10% | -$48.2K | 0.02% | 559 |
|
|
2024
Q1 | $418K | Buy |
6,172
+271
| +5% | +$18.4K | 0.02% | 582 |
|
|
2023
Q4 | $398K | Sell |
5,901
-10
| -0.2% | -$674 | 0.02% | 552 |
|
|
2023
Q3 | $400K | Buy |
5,911
+921
| +18% | +$62.4K | 0.03% | 473 |
|
|
2023
Q2 | $357K | Sell |
4,990
-110
| -2% | -$7.87K | 0.03% | 523 |
|
|
2023
Q1 | $354K | Sell |
5,100
-4,539
| -47% | -$315K | 0.03% | 547 |
|
|
2022
Q4 | $654K | Buy |
9,639
+4,656
| +93% | +$316K | 0.05% | 346 |
|
|
2022
Q3 | $273K | Buy |
4,983
+1,038
| +26% | +$56.9K | 0.02% | 573 |
|
|
2022
Q2 | $261K | Sell |
3,945
-439
| -10% | -$29K | 0.02% | 590 |
|
|
2022
Q1 | $291K | Sell |
4,384
-13
| -0.3% | -$863 | 0.02% | 632 |
|
|
2021
Q4 | $256K | Buy |
4,397
+428
| +11% | +$24.9K | 0.02% | 701 |
|
|
2021
Q3 | $238K | Buy |
3,969
+132
| +3% | +$7.92K | 0.02% | 404 |
|
|
2021
Q2 | $230K | Buy |
+3,837
| New | +$230K | 0.02% | 659 |
|
|
2021
Q1 | – | Sell |
-4,873
| Closed | -$244K | – | 670 |
|
|
2020
Q4 | $244K | Sell |
4,873
-20,508
| -81% | -$1.03M | 0.03% | 537 |
|
|
2020
Q3 | $1.39M | Buy |
+25,381
| New | +$1.39M | 0.11% | 202 |
|
|
2020
Q1 | – | Sell |
-4,938
| Closed | -$246K | – | 132 |
|
|
2019
Q4 | $246K | Buy |
+4,938
| New | +$246K | 0.03% | 468 |
|